This Labrador retriever with forelimb osteosarcoma had a good quality of life for more than a year while receiving only analgesic therapy.
Dec 1, 2009
By:
Louis-Philippe de Lorimier, DVM, DACVIM (oncology)
Certain cases of cancer may respond well to conservative analgesic therapy initially but eventually require multimodal analgesia.
|
Various tumor-related factors may lead to elevated calcium concentrations that can greatly contribute to a cancer patient's morbidity. Here's how to help alleviate the suffering associated with this common paraneoplastic syndrome.
May 1, 2007
By:
Pamela Lucas, DVM, Hugues Lacoste, DVM, DACVIM (oncology), Louis-Philippe de Lorimier, DVM, DACVIM (oncology), Timothy M. Fan, DVM, PhD, DACVIM (internal medicine, oncology)
About 45% to 65% of hypercalcemic dogs and 10% to 30% of hypercalcemic cats have underlying neoplasia.
|
Most mammary tumors in cats are malignant, and metastasis is common. The prognosis depends on how far the cancer has spread and the tumor's biologic behavior, among other things. Find out how to improve the outcome in these critically ill cats.
Jun 1, 2006
By:
Jackie Wypij, DVM, DACVIM (oncology), Timothy M. Fan, DVM, PhD, DACVIM (internal medicine, oncology), Louis-Philippe de Lorimier, DVM, DACVIM (oncology)
Mammary tumors are the third most common feline cancer, 1-3 accounting for 10.3% to 12% of all diagnosed tumors.
|
These tumors in dogs are difficult to completely resect, so the prognosis for long-term survival is guarded. But new avenues of treatment are being discovered, and treatment protocols already in place can extend and enhance dogs' lives.
Jun 1, 2006
By:
David A. Heller, DVM, Louis-Philippe de Lorimier, DVM, DACVIM (oncology), Timothy M. Fan, DVM, PhD, DACVIM (internal medicine, oncology)
Transitional cell carcinoma of the urinary bladder is by far the most common neoplasm of the urinary system in dogs.
|
Jun 1, 2006
By:
Louis-Philippe de Lorimier, DVM, DACVIM (oncology)
Cancer remains one of the most common serious ailments of aging pets. However, better diagnostic capabilities and improved therapeutic options now often translate into enhanced quality of life and longer survival.
|
Since many of the clinical signs of hepatobiliary tumors are nonspecific, these tumors may be advanced at diagnosis. However, using the correct diagnostic tools, including cytology, tissue biopsy, and abdominal imaging, may lead to an earlier diagnosis and a better outcome.
Jun 1, 2006
By:
Jackie Wypij, DVM, DACVIM (oncology), Timothy M. Fan, DVM, PhD, DACVIM (internal medicine, oncology), Louis-Philippe de Lorimier, DVM, DACVIM (oncology)
Metastatic, disseminated, and locally infiltrative cancers, including metastatic carcinoma, melanoma, lymphoma, hemangiosarcoma, and histiocytic sarcoma, can often affect the hepatic parenchyma.
|
No matter the type of cancer, pain is common at various stages, causing not only suffering but also other adverse physiological effects. Make sure you're aware of and are using the best management options—from surgery to radiation to drugs.
May 1, 2005
By:
Louis-Philippe de Lorimier, DVM, DACVIM (oncology), Timothy M. Fan, DVM, PhD, DACVIM (internal medicine, oncology)
Recent publications, ongoing prospective studies, and better knowledge of the available therapeutic options should provide the necessary framework for appropriate pain management in cancer-bearing pets.
|
They may not speak, but our patients with cancer can still tell us they're in pain. Are we getting the message? With careful observation and good client communication, we can identify pain. And with an awareness of the cancers and procedures known to cause pain, we can offer preemptive pain control.
May 1, 2005
By:
Louis-Philippe de Lorimier, DVM, DACVIM (oncology), Timothy M. Fan, DVM, PhD, DACVIM (internal medicine, oncology)
Pain negatively affects quality of life as well as many important physiological functions, so controlling it in all patients should be a top priority.
|
You'll likely encounter patients with these neoplasms in your practice. Luckily, many treatment options are available, such as surgery, radiation therapy, and chemotherapy—and new treatments are on the horizon.
Apr 1, 2005
By:
Timothy M. Fan, DVM, PhD, DACVIM (internal medicine, oncology), Louis-Philippe de Lorimier, DVM, DACVIM (oncology)
Because you will likely encounter canine cutaneous mast cell tumors in your practice, this review article focuses on summarizing the therapeutic options available for treating canine mast cell tumors. With a better understanding of available treatment regimens, you will be able to educate and guide pet owners regarding the treatment options that may best suit their dogs.
|
|
Featuring Information from:
